Cargando…

Role of Serum Levels of Vascular Endothelial Growth Factor and Its Receptor in Retinopathy of Prematurity

BACKGROUND: Retinopathy of prematurity (ROP) is a disorder of developing retina of low birth weight preterm infants which can lead to blindness. One theory attributes the fibrosis seen in ROP to deregulation of vascularization in the retina. Vascular endothelial growth factor (VEGF) is one of the im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goswami, Binita, Goyal, Monika, Beri, Sarita, Garg, Rajiv, Saili, Arvind, Jain, Anju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575799/ https://www.ncbi.nlm.nih.gov/pubmed/26396701 http://dx.doi.org/10.5812/ijp.2373

Ejemplares similares

Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity
por: Chen, Xuting, et al.
Publicado: (2019)

Anti-vascular endothelial growth factor in the management of retinopathy of prematurity: A survey among the members of Indian Retinopathy of Prematurity Society
por: Gangwe, Anil, et al.
Publicado: (2021)

Intraocular and systemic levels of vascular endothelial growth factor in advanced cases of retinopathy of prematurity
por: Velez-Montoya, Raul, et al.
Publicado: (2010)

Anti-vascular endothelial growth factor therapy in retinopathy of prematurity: An updated literature review
por: Alzuabi, Asma K., et al.
Publicado: (2022)

Vascular Endothelial Growth Factor Signaling in Models of Oxygen-Induced Retinopathy: Insights Into Mechanisms of Pathology in Retinopathy of Prematurity
por: Ramshekar, Aniket, et al.
Publicado: (2021)

Progression of retinal vascularization after intravitreal anti-vascular-endothelial growth factor therapy in retinopathy of prematurity
por: Mirghorbani, Masoud, et al.
Publicado: (2022)

Commentary: Antivascular endothelial growth factor and retinopathy of prematurity
por: Dudani, Ajay Indur, et al.
Publicado: (2019)

Anti-vascular Endothelial Growth Factor Treatment of Retinopathy of Prematurity: Efficacy, Safety, and Anatomical Outcomes
por: Kang, Hyun Goo, et al.
Publicado: (2018)

Commentary: Looking beyond anti-vascular endothelial growth factor – Novel therapeutic targets for retinopathy of prematurity
por: Dogra, Mohit, et al.
Publicado: (2021)

Commentary: Are we there yet? Role of anti-vascular endothelial growth factor and laser in the management of retinopathy of prematurity
por: Sindal, Manavi D, et al.
Publicado: (2021)

Diabetic retinopathy and vascular endothelial growth factor
por: Khazaei, Majid
Publicado: (2013)

Expression of vascular endothelial growth factor and pigment epithelial-derived factor in a rat model of retinopathy of prematurity
por: Hartmann, John S., et al.
Publicado: (2011)

Characteristics of Eyes Developing Retinal Detachment After Anti-vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity
por: Kondo, Chiori, et al.
Publicado: (2022)

Intravitreal Anti-vascular Endothelial Growth Factor Injection for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis
por: Taher, Nada O., et al.
Publicado: (2022)

Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2–induced intravitreal neovascularization in a rat model of retinopathy of prematurity
por: Wang, Haibo, et al.
Publicado: (2014)

Serum vascular endothelial growth factor is a biomolecular biomarker of severity of diabetic retinopathy
por: Ahuja, Sukriti, et al.
Publicado: (2019)

A Systematic Review and Meta-Analysis on the Safety of Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Retinopathy of Prematurity
por: Pertl, Laura, et al.
Publicado: (2015)

Safety and efficacy of intravitreal anti vascular endothelial growth factor for severe posterior retinopathy of prematurity with flat fibrovascular proliferation
por: Maitra, Puja, et al.
Publicado: (2023)

Correlation between tear levels of vascular endothelial growth factor and vitamin D at retinopathy of prematurity stages in preterm infants
por: Murugeswari, Ponnalagu, et al.
Publicado: (2023)

The role of serum apelin in retinopathy of prematurity
por: Ali, Yasser F, et al.
Publicado: (2017)

Expression of Total Vascular Endothelial Growth Factor and the Anti-angiogenic VEGF(165)b Isoform in the Vitreous of Patients with Retinopathy of Prematurity
por: Zhao, Min, et al.
Publicado: (2015)

Timing of laser following intravitreal anti-vascular endothelial growth factor injections for aggressive posterior zone 1 retinopathy of prematurity
por: Vinekar, Anand
Publicado: (2021)

Vitreous and Serum Concentrations of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Proliferative Diabetic Retinopathy
por: Muhiddin, Habibah Setyawati, et al.
Publicado: (2020)

Relationship between Serum Vascular Endothelial Growth Factor Levels and Stages of Diabetic Retinopathy and Other Biomarkers
por: Abu-Yaghi, Nakhleh E., et al.
Publicado: (2020)

Comparison of efficacy between anti-vascular endothelial growth factor (VEGF) and laser treatment in Type-1 and threshold retinopathy of prematurity (ROP)
por: Li, Zijing, et al.
Publicado: (2018)

The retinal vascular growth rate in babies with retinopathy of prematurity could indicate treatment need
por: Padhi, Tapas Ranjan, et al.
Publicado: (2022)

Blockade of Vascular Endothelial Growth Factor Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy
por: He, Jianbo, et al.
Publicado: (2015)

Treatment for Nontype 1 Retinopathy of Prematurity by Intravitreal Injection of Antivascular Endothelial Growth Factor Drugs
por: Zhang, Haitao, et al.
Publicado: (2022)

Refractive Outcomes of 4-Year-old Children after Intravitreal Anti-vascular Endothelial Growth Factor versus Laser Photocoagulation for Retinopathy of Prematurity
por: Kang, Hyun Goo, et al.
Publicado: (2019)

Role of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) in the Treatment of Retinopathy of Prematurity: A Narrative Review in the Context of Middle-Income Countries
por: Dogra, Mangat Ram, et al.
Publicado: (2023)

Short-term effects of intravitreal anti-vascular endothelial growth factor agents on body weight and multiple systems after treatment for retinopathy of prematurity
por: Chen, Jing, et al.
Publicado: (2023)

Stage 5 retinopathy of prematurity: An update
por: Sen, Parveen, et al.
Publicado: (2018)

Evaluation of Brainstorming Session as a Teaching-learning Tool among Postgraduate Medical Biochemistry Students
por: Goswami, Binita, et al.
Publicado: (2017)

Speed of Retinal Vascularization in Retinopathy of Prematurity: Risk and Protective Factors
por: Solans Pérez de Larraya, Ana Maria, et al.
Publicado: (2019)

Up close with the vascular loops in aggressive posterior retinopathy of prematurity
por: Raju, Biju, et al.
Publicado: (2019)

Retinopathy of prematurity
por: Bhende, Pramod S
Publicado: (2020)

Use of an online screening algorithm - Weight, Insulin-derived growth factor 1, Neonatal Retinopathy of Prematurity (WINROP) for predicting retinopathy of prematurity in Indian preterm babies
por: Sute, Smith Snehal, et al.
Publicado: (2021)

The Short-Term Effects of Intravitreal Injection of Bevacizumab on the Plasma Levels of Vascular Endothelial Growth Factor, Insulin-Like Growth Factor-1, and Growth Parameters in Infants with Retinopathy of Prematurity
por: Sedaghat, Ahad, et al.
Publicado: (2020)

Relationship between vitreous and serum vascular endothelial growth factor levels, control of diabetes and microalbuminuria in proliferative diabetic retinopathy
por: Baharivand, Nader, et al.
Publicado: (2012)

Incidence and Risk Factors Associated with Retinopathy of Prematurity in Peru
por: Carranza-Mendizabal, Carmen Sarita, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2hvnhm9r6vfv67k7likchrfejm